Lampsai Banner.png

DAVOS 2019: CREATING A STAGE

Lampsai Banner.png

First-Ever Event dedicated to the Science of Psychedelics for Mental Health in Davos

Lampsai organised the first-ever event related to brain science & psychedelics on the Promenade in Davos during the World Economic Forum. Our goal was to add to the understanding of what creates anxiety, depression, addiction, and other challenges of the brain, and bring forward alternative healing modalities which target the source of these conditions, and heal them at root cause rather that only addressing the symptoms.

The panel discussion attracted great interest among the WEF participants and generated a long waiting list. The session led to significant rise in public awareness around the growing global mental health concerns illuminating both ‘why' and ’what’ of the subject. 

24.01.2019_LAMPSAI_Invite_screen.png
 

DAVOS 2019: Panel Discussion

Dr. Robin Carhart-Harris

Head of the Centre for Psychedelic Research, Division of Brain Sciences, Faculty of Medicine, Imperial College London

POyIG6FD.jpeg

Christian Angermayer

Entrepreneur & Investor. Founder & CEO, Apeiron Investment Group

OQIhriX3.jpeg

Khaliya

MPH, Health Futurist and Co-founder, Falkora

T15OOnEP.jpeg

James Hewitt

Head of Science & Innovation at Hintsa Performance and an Active Researcher at Loughborough University

tQ0q049F.jpeg

Prof. Olivier Oullier

Neuroscientist. Professor of Behavioral and Brain Sciences at Aix-Marseille University

eGgBkg3l.jpeg

Lars Christian Wilde

President, Chief Business Officer, and Co-Founder of COMPASS Pathways